Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

A2A Pharma

A2A Pharma
2016 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$3M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of a healthcare therapy intended to treat Leukemia, pancreatic and liver cancer. The company's therapy is useful to treat antibiotic resistant bacterial infections and cancer and bacterial infections like Tuberculosis though its proprietary computational system, enabling healthcare professionals and physicians to treat their patients in an enhanced way.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 101 6th Avenue
  • New York, NY 10013
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore A2A Pharma’s full profile, request a free trial.

A2A Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 06-Feb-2018 $3M 00.00 Completed Generating Revenue
3. Accelerator/Incubator 12-Dec-2017 00000 Completed Generating Revenue
2. Accelerator/Incubator 02-Nov-2016 $200K $200K 00.00 Completed Generating Revenue
1. Seed Round 01-Apr-2016 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

A2A Pharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000.00 19-Jul-2018 00000 0000000 Other Healthcare Technology Systems 00000 0000000 00.0
To view this company’s complete investment and acquisition history, request access »

A2A Pharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator 000 0000 000000 0
IndieBio Accelerator/Incubator Minority 000 0000 000000 0
SOSV Venture Capital Minority 000 0000 000000 0

A2A Pharma Executive Team (7)

Name Title Board
Seat
Contact
Info
Sotirios Stergiopoulos Co-Founder, President and Chief Executive Officer
Edward Painter Co-Founder, Chief Information Officer and Chairman
Chaemin Lim Ph.D Chief Scientific Officer
Brendan Kelly Ph.D Co-Founder and Advisor
Sridhar Vempati Ph.D Co-Founder and Advisor
You’re viewing 5 of 7 executives. Get the full list »

A2A Pharma Board Members (3)

Name Representing Role Since Contact
Info
Andrew Dean Ph.D A2A Pharma Board Member 000 0000
Edward Painter A2A Pharma Co-Founder, Chief Information Officer and Chairman 000 0000
Matthew Welsch Ph.D A2A Pharma Co-Founder and Board Member 000 0000